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Abstract
The Gene Ontology (GO) resource provides dynamic controlled vocabularies to provide an information-rich resource to aid
in the consistent description of the functional attributes and subcellular locations of gene products from all taxonomic
groups (www.geneontology.org). System-focused projects, such as the Renal and Cardiovascular GO Annotation Initiatives,
aim to provide detailed GO data for proteins implicated in specific organ development and function. Such projects support
the rapid evaluation of new experimental data and aid in the generation of novel biological insights to help alleviate human
disease. This paper describes the improvement of GO data for renal and cardiovascular research communities and
demonstrates that the cardiovascular-focused GO annotations, created over the past three years, have led to an evident
improvement of microarray interpretation. The reanalysis of cardiovascular microarray datasets confirms the need to
continue to improve the annotation of the human proteome.
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Introduction
The Gene Ontology (GO) [1,2] is the most widely used
biomedical ontology, with GO terms and gene product annota-
tions displayed by virtually every biological sequence database
(including UniProt Knowledgebase, NCBI EntrezGene, Gene-
Cards, Reactome and Ensembl). It is the de facto standard for
effective analysis of high-throughput datasets. The GO uses
structured controlled vocabulary terms, to describe three aspects of
a gene product’s attributes: the molecular function(s), or activities that
a gene product can directly perform; the biological process(es) it
contributes to; and the subcellular locations (cellular component) in
which it is active [3]. Over 34,000 GO terms describe a wide
range of concepts to differing levels of specificity and are organised
as directed acyclic graphs using descriptive relationship types [4].
Full information describing each GO term, such as definitions and
synonyms, the associated gene products and publications can be
obtained via the QuickGO browser [5].
GO Consortium member groups include a wide range of model
organism and database groups who are all involved in the
application of automated prediction and/or manual curation
methods to generate associations or ‘annotations’ between specific
GO terms and genes or gene products for many species [4]. The
GO is developed in response to user requests or GO Consortium
activities [6,7]. The four major contributors to the annotation of
the human proteome are the UniProt Consortium, the Renal and
Cardiovascular GO Annotation Initiatives and the GO Consor-
tium Reference Genome Group [8–12].
The renal and cardiovascular research communities have
embraced high-throughput technologies to identify, quantify and
characterise relevant pathways and networks [13–16]. Conse-
quently, the Renal and Cardiovascular Initiatives [10,11] were
instigated to support the interpretation of these datasets by
providing a comprehensive public resource of GO annotations for
targeted protein sets. The annotation focus of these two initiatives
is proteins implicated in renal and cardiovascular development,
function and disease. Both initiatives concentrate on improving the
ontology describing renal and cardiovascular-associated processes
and then use this enriched GO vocabulary to summarize
published experimentally validated knowledge for relevant
proteins.
Electronic annotation pipelines are invaluable in supplying
many millions of valid GO annotations to a wide range of
sequences. Applied electronic annotation methods exploit the
information available from protein signature [17] or orthology
data [18] as well as manual and automated annotation efforts [8].
Each prediction method must generate high-quality annotations,
which constrains the number and specificity of their predictions. In
contrast, manual annotation requires highly-trained biocurators to
read and evaluate evidence from published literature in order to
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associate appropriate GO terms to proteins [19,20]. Indisputably,
manual annotation is a labor-intensive process, however, it does
apply GO terms which are far more informative and accurate than
can be achieved by the current electronic pipelines, providing a
comprehensive, detailed summary of the published know-
ledge about a gene product. For example, the human protein
WNT7A (www.ebi.ac.uk/QuickGO/GProtein?ac = O00755) has
been annotated with the electronic InterPro2GO annotation
GO:0007275, ‘multicellular organismal development’, however, the
manual annotation effort has been able to additionally assign the
more descriptive terms GO:0050768, ‘negative regulation of neurogen-
esis’ and GO:0051965, ‘positive regulation of synaptogenesis’, to this
protein.
There are two general approaches which are used for the
manual GO annotation of proteins: the protein-centric approach
resulting in comprehensive annotation of a single protein (or
protein family) or the process-centric approach in which a
biocurator focuses on the annotation of all proteins involved in a
single process. The protein-centric approach, has the advantage of
identifying a protein’s involvement in multiple processes, however
it does mean that the biocurator may not appreciate the ‘bigger
picture’ relevant to each process, and is more likely to use the
available GO terms, rather than request new, more-specific ones.
The Renal and Cardiovascular Initiatives mainly utilise the
process-centric annotation approach, which leads to detailed
curation of groups of similarly functioning proteins. Annotating to
a specific process allows the biocurator to gain a more thorough
understanding of the role played by each protein within a process,
more consistent annotation of these proteins and consequently
specific new GO terms tend to be more frequently requested,
leading to improvements in a particular GO domain (e.g., the
expansion of the plasma lipoprotein particle ontology from one
term to eleven terms), or development of an extensive ontology, for
example expanding the heart development [21] and kidney
development ontologies). Process-focused GO annotation comple-
ments the existing GO annotations created by various model
organism databases and specialist groups whose annotation sets
are not focused on a particular biological area. Together both
approaches provide the depth (process-focused approach) and
breadth (non-focused approach) of annotations needed for
information-rich interpretation of scientific studies.
Both the Renal and Cardiovascular Initiatives have enhanced
the quality and quantity of GO terms associated with human
proteins. Now that the more established Cardiovascular Initiative
has entered its fourth year, we are able to demonstrate how the
resulting cardiovascular annotation set can better assist in the
interpretation of microarray datasets.
Results
Impact of process-focused annotation on the depth of
GO annotation
Improvements to protein annotation were measured by
comparing the number and specificity of annotations supplied to
human proteins by the Renal and Cardiovascular Initiatives with
those supplied by other groups to the human proteome. The
Cardiovascular and Renal Initiatives have increased the average
number of GO annotations/protein for their prioritised protein
lists, compared to the average number of GO annotations/protein
in the human proteome. For example, on 11th July 2011 the
human proteome was manually annotated with an average of 10
GO terms per protein (15,866 proteins), whereas, the 4,500
human proteins prioritised for annotation by the Renal and
Cardiovascular Initiatives have an average of 16 manual
annotations per protein. Improvements to the human GO
annotation set were also measured by comparing the specificity
of annotations supplied to human proteins by the Renal and
Cardiovascular Initiatives with those supplied by other groups.
This comparison demonstrated that the annotations contributed
by the system focused annotation approaches supply high
information content, indicated by the increase in the specificity
of the terms applied (defined in terms of granularity, Figure 1).
Performing the Mann Whitney U test on this data confirms that
the median granularity of GO terms used in human protein
annotation by both the Cardiovascular and Renal Initiatives is 8.0
(inter quartile range 6–10), compared to a median granularity of
7.0 (inter quartile range 5–9), for the GO terms used by other
groups manually annotating to the human proteome (P,0.0001).
Impact of process-focused annotation on ontology
development
At the start of the Renal and Cardiovascular GO initiatives,
only 12 terms for heart development and 22 terms for kidney
development were available in GO to cover the complex processes
involved in the development, specification and differentiation of
these organs and highly differentiated tissue specific cells.
Therefore, to achieve improvements in these areas, both curator
and workshop-led ontology development activities were instigated.
Cross-species collaborations ensured that organism anatomy was
correctly applied by the new GO terms and facilitated species-
neutral ontology development, which supports the transfer of
annotations from characterised to poorly-studied, closely-related
species. These activities generated 283 cardiovascular terms [21]
and 479 renal terms, and a small section of the improved GO for
kidney development terms, with associated annotations, is shown
(Figure 2; a search at AmiGO http://amigo.geneontology.org
with GOC:mtg_heart or GOC:mtg_kidney gives a full list of these
new GO terms). Improving the ontology enables more specific
gene groups to be created, For example, using the new kidney
terms in the ontology, 24 human proteins are now annotated with
the informative biological process GO term ‘metanephric renal vesicle
morphogenesis’, rather than the only appropriate GO term previously
available ‘kidney development’, which is associated with over 200
human proteins. In comparison, there are currently only 34 terms
describing the biological processes involved in eye development,
demonstrating that the ontologies relevant to complex organ
systems without focused annotation efforts are not being prioritised
for ontology development.
Impact of process-focused annotation on high-
throughput data analysis
The Cardiovascular Initiative began in 2007 and the manual
annotations added since then have led to the generation of a large
GO annotation dataset. This set was therefore chosen to examine
the possible impact on the analysis of two separate high-
throughput datasets, as described below.
Analysis 1. A microarray dataset was chosen for reanalysis
that had examined differentially regulated genes in peripheral
blood mononuclear cells from patients with systemic scleroderma-
related pulmonary arterial hypertension (PAH-SSc) com-
pared to healthy controls [22]. The original interpretation of
this microarray dataset was achieved using GenMAPP and
MAPPFinder which identified 9 GO terms as enriched in this
dataset, including ‘angiogenesis’, ‘chemotaxis’ and ‘inflammatory response’
(see Table 1). Without the raw data we were unable to use the
MAPPFinder tool used by Grigoryev et al., instead we used three
different GO term enrichment tools to look at how data
Mammalian Gene Ontology Curation
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Figure 1. Distribution of GO term specificity by annotation source. Accumulative frequency of the distribution of GO terms applied in
human annotations. Manual annotations created by the Cardiovascular and Renal Initiative, compared to those created by annotation groups
without a system focused approach. Mann Whitney U confirms that the median granularity of GO terms used in human protein annotation by the
Cardiovascular and Renal Initiatives is 8.0 (inter quartile range 6–10), compared to a median granularity of 7.0 (inter quartile range 5–9), for the GO
terms used by other groups manually annotating to the human proteome (P,0.0001).
doi:10.1371/journal.pone.0027541.g001
Figure 2. AmiGO ‘Tree View’ image of part of the kidney developmental process ontology. The ‘tree view’ in AmiGO (http://amigo.
geneontology.org) showing the GO term parents of GO:0003337 ‘mesenchymal to epithelial transition involved in metanephros morphogenesis’. The
most specific twelve GO terms (shaded) were amongst the 470 new terms created following the kidney development ontology workshop. The
numbers in brackets indicate the number of human proteins annotated to the GO term, or one of its child terms (07th October 2011). [I] is_a parent-
child relationship, ‘P’ part_of parent-child relationship.
doi:10.1371/journal.pone.0027541.g002
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interpretation changes with the addition of new GO annotations.
The analysis tools GO-Elite, the sister program of MAPPFinder
[23], which was expected to produce similar results to
MAPPFinder, Ontologizer [24] and ProfCom GO [25]. The
latter two tools were chosen as they were widely-respected,
popular tools that facilitated the inclusion of specified and filtered
GO annotation datasets.
Re-analysis of the original Grigoryev et al. dataset with GO-Elite
(Table S1) confirmed that the majority of the GO terms identified
by Grigoryev et al. were also significantly enriched using the 2011
dataset. However, 3 terms, ‘cell-cell signalling’, ‘sensory perception’ and
‘antimicrobial humoral response’ described by Grigoryev et al. as being
enriched were no longer identified. In contrast to this we found
only one GO term significantly enriched in the Ontologizer
analysis and one term in the ProfCom GO analysis that were also
reported as enriched by Grigoryev et al. (‘cellular component movement’
and ‘inflammatory response’ respectively, see Table 1). However, GO
terms closely related to several of the terms identified by Grigoryev
et al. were enriched using Ontologizer and ProfCom. For example,
the Ontologizer analysis identifies the GO terms ‘response to stimulus’
and ‘locomotion’, and these terms are parents to the ‘chemotaxis’ term
identified by Grigoryev et al. (see Figure 3 and Table 2). The
ProfCom GO analysis also enriched for the ‘chemotaxis’-related
term ‘leukocyte migration’, and the ‘antimicrobial humoral response’-
related term ‘response to lipopolysaccharide’ (Table 3).
The re-analysis of the Grigoryev et al. dataset using the more
recent GO annotation datasets identified the significant enrich-
ment of additional GO terms, which were not originally reported.
In total the GO-Elite analysis identified 696 significantly enriched
‘biological process’ GO terms, Ontologizer 24 GO terms, and
ProfCom GO 10 GO terms, many of which are relevant to the
PAH-SSc phenotype such as ‘response to cytokine stimulus’ , ‘response to
organic cyclic substance’ and ‘regulation of NF-kappaB import into nucleus’
(Tables S1, 2 and 3). In order to fully examine the impact of the
Cardiovascular Initiative on the analysis of the PAH-SSc dataset,
the term enrichment was repeated using the March 2011 GO
annotation dataset from which all of the Cardiovascular Initiative
submitted annotations had been removed (13,000 annotations).
Unfortunately, only the Ontologizer and ProfCom GO tools
provided the facility to input these filtered datasets. Removing the
Cardiovascular Initiative annotations decreased the significance of
the majority of the enriched GO terms, and 6 GO terms were no
longer significantly enriched (Table 2). Several of these 6 GO
terms are relevant to the disease phenotype; e.g. ‘cytokine production’
and ‘nitric oxide metabolic process’ (Table 2), confirming an improved
interpretation of the dataset with the annotations supplied by the
Cardiovascular Initiative. A difference in the analysis of the PAH-
SSc dataset was also seen using ProfCom GO and the full GO
annotation dataset compared to the filtered annotation dataset
(Table 3), with relevant terms such as ‘positive regulation of nitric oxide
biosynthetic process’ and ‘cytokine-mediated signalling pathway’ only
significantly enriched with the inclusion of the Cardiovascular
Initiative annotations.
Analysis 2. A macrophage microarray dataset was chosen as
macrophages play a key role in atherosclerosis and because proteins
associated with immune system processes have not previously been
targeted for GO annotation. The microarray dataset contained
342 mouse genes differentially expressed in resolution-phase
macrophage verses naı¨ve and inflammatory macrophages [26].
Resolution-phase macrophages are a newly identified class of
macrophage, with a hybrid phenotype between the alternatively and
classically activated macrophage classes [27]. After full annotation of
37 of these genes we used Ontologizer to analyse the full
differentially expressed dataset using the mouse GO annotation
dataset available before our targeted annotation of a subset of these
genes (December 2010) and compared this to the analysis of the
same microarray dataset using a later version of the mouse GO
annotation dataset (April 2011), which would have also included
annotations created during this time by Mouse Genome Informatics.
GO term enrichment of this macrophage microarray dataset using
the December 2010 GO dataset identified 2 significantly enriched
‘biological process’ GO terms: ‘cell activation’ and ‘immune system process’
(Table 4). The reanalysis using the more recent GO annotation
dataset (April 2011) substantially improved the interpretation of the
dataset, not only identifying an additional 7 significantly enriched
GO terms, but also enriching for GO terms which suggest an
involvement of resolution-phase macrophages in stimulating
‘leukocyte apoptosis’, ‘cytokine production’ and ‘cell proliferation’ [26].
Table 1. Comparison of PAH-SSc microarray data analysis using MAPPFinder in 2008 and GO-Elite, Ontologizer and ProfCom GO in
2011.
GenMAPP analysis
Grigoryev et al, 2008
GenMAPP GO-Elite
analysis June 2011
Ontologizer analysis
March 2011
ProfCom GO analysis
March 2011
GO term Z-score S P Z-score
S
t=262
P
t=17158
p-value
(Adj)
S
t=264
P
t=18249 p-value
S
t=265
P
t=18257
angiogenesis 5.534 6 41 6.3 11 137 1 15 248 8.00E-02 9 122
chemotaxis 6.457 10 111 4.75 20 484 1 20 525 7.50E-02 9 121
inflammatory response 8.429 18 179 6.6 17 265 1 23 361 2.03E-04 16 224
cellular component movement 4.378 11 108 7.5 28 506 0 35 701 9.90E-02 8 98
G-protein coupled receptor signaling 5.576 15 825 3.66 18 524 1 19 573 N/A N/A N/A
cell-cell signaling 3.208 11 283 20.36 8 597 1 15 877 N/A N/A N/A
sensory perception 2.323 7 472 N/A N/A N/A 1 3 835 N/A N/A N/A
antimicrobial humoral response 2.706 6 84 N/A N/A N/A N/A N/A N/A N/A N/A N/A
Negative regulation of cell
proliferation
3.383 9 136 4.07 16 403 1 16 399 N/A N/A N/A
Significant Z-scores and p-values are highlighted in bold text. GO processes with Z scores .1.96 identified by MAPPFinder and GO-Elite are considered as significantly
enriched [22]; adjusted p-values,0.1 identified by Ontologizer [24] are considered as significantly enriched; P-values.,0.01 identified by ProfCom GO [25] are
considered as significantly enriched. S = study count, P = population count, t = number of protein IDs.
doi:10.1371/journal.pone.0027541.t001
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Discussion
The interpretation of large-scale genetic, genomic and proteo-
mic studies depends on computational analyses that incorporate
functional annotations. The large number of publications from
microarray and proteomics investigations which evaluate the
involvement of large sets of genes or proteins in a particular
process or response demonstrate that ontological resources, such as
Gene Ontology, are routinely used to inform results.
There is a multitude of freely available GO term enrichment
tools to use for the interpretation of high-throughput datasets.
These tools apply different analysis methods, statistics, multiple
correction methods, filters and versions of the GO Consortium
ontology and annotation files to analyse gene or protein lists [28].
In this paper, we compare the analysis of a single microarray
dataset using four different term enrichment tools, each of which
provide different, but often overlapping, data interpretation.
The Ontologizer Parent-Child Intersection analysis takes into
account relationships within the GO hierarchy [24] and identifies
24 GO terms as enriched in the PAH-SSc dataset (Table 2). This
approach avoids false positives by only regarding a parent term as
significant and not any of its child terms, which may have also
been over-represented in the annotation set. In contrast, ProfCom
GO uses the computationally efficient greedy heuristics algorithm,
which identifies the best local solution while searching the global
optimum [25] and identifies only 10 significantly enriched GO
terms (Table 3). While GO-Elite uses a term-for-term approach,
giving a standardised difference (Z-score) based on a hypergeo-
metric distribution [23], and hence finds 700 GO terms that are
significantly enriched in this dataset (Table S1).
Such variability in the number of GO terms enriched in each of
these analysis tools brings into question the robustness of the GO
term enrichment approach, however, there is some consistency in
the results obtained and an enrichment of several ‘biological
processes’ with known roles in pulmonary arterial hypertension
(PAH) and scleroderma, with each of the tools. For example,
vascular remodeling plays an important role in PAH [29] and GO
terms relating to this process are enriched using all of the four
tools, ‘angiogenesis’ (MAPPFinder and GO-Elite), ‘positive regulation of
smooth muscle cell proliferation’ (ProfCom GO and GO-Elite), ‘nitric
oxide metabolic process’ (Ontologizer) and ‘positive regulation of nitric oxide
biosynthetic process’ (ProfCom GO and GO-Elite, Tables 1, 2, 3 and
S1). In addition, systemic scleroderma is an autoimmune disease
[22] and the consistent significant enrichment of ‘cytokine production’
(Ontologizer and GO-Elite), ‘cytokine-mediated signaling pathway’
(ProfCom GO and GO-Elite), and ‘inflammatory response’ (MAPP-
Finder, ProfCom GO and GO-Elite) reflects the inflammatory
aspect to this disease. The comparison of GO terms enriched using
these four tools therefore confirms that despite the different
outputs there is some reproducibility in the interpretation of this
dataset. Some specific GO terms identified in only one or two of
the analyses also are consistent with the inflammatory nature of
the disease, such as ‘regulation of NF-kappaB import into nucleus’ and
‘leukocyte migration’, and also reflect the treatment of the disease, for
example ‘response to organic cyclic substance’, all of the PAH-SSc
patients were on medication, the majority of which were organic
cyclic compounds [22].
A comparison of the significantly enriched GO terms identified
using the Cardiovascular Initiative inclusive GO annotation dataset
against those enriched without these annotations, confirmed that
annotations created by the Cardiovascular Initiative have improved
the analysis of the PAH-SSc dataset, using both Ontologizer and
ProfCom GO (Tables 2 and 3). Hence, our analyses confirm that
GO annotations created through three years of annotation focused
on cardiovascular-relevant proteins, rather than specific annotation
of just a few genes within a study dataset, has led to a significantly
improved interpretation of this PAH-SSc dataset.
Figure 3. QuickGO term display. QuickGO (www.ebi.ac.uk/QuickGO) ancestor chart showing information for GO:0006935 ‘chemotaxis’ and its
‘is_a’ parent relationships within the hierarchical directed acyclic graph. The GO terms ‘chemotaxis’, ‘locomotion’ and ‘response to stimulus’ are
highlighted to illustrate their parent-child relationships. The child term details are displayed for the GO term ‘chemotaxis’.
doi:10.1371/journal.pone.0027541.g003
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Similarly, the comprehensive GO annotation of only 37 of the
342 mouse genes differentially expressed in resolving macrophage
versus naı¨ve and inflammatory macrophages, demonstrates that
improved annotation of even a small number of process-specific
proteins can result in significant enrichment of relevant GO terms
in the analysis of a specific large-scale proteomic or genomic
dataset (Table 4).
Conclusion
The Cardiovascular and Renal GO Annotation Initiative
approaches have been able to supply high-quality, detailed
annotations and specific GO terms. A limited analysis of this
data, through reanalysis of GO term enrichment results of the
human PAH-SSc and mouse macrophage datasets demonstrate
the impact that these focused annotation efforts can have on the
interpretation of high-throughput datasets. These results also
confirm the need for comprehensive, information-rich annotation
datasets and a more knowledgeable use of existing public data to
aid in pathway identification and to fully harness bioresources and
biomodelling. Hence the continued improvements in both protein
GO annotation and ontology development can enable researchers
to gain improved biological insights into their proteins of interest
and hence guide their future research towards alleviating various
human diseases.
Although the Renal and Cardiovascular Initiatives’ curators
have focused on the annotation of a limited number of proteins,
these projects aim to annotate a wide range of functions and
processes, not just those associated with renal and cardiovascular
processes. However, the production of a process bias in the human
annotation dataset is a possible side effect of this approach, which
could impact on the analysis of high-throughput datasets. As yet,
we have found no evidence of unexpected cardiovascular and
renal terms, being detected in term enrichment analyses. Recent
microarray analysis, using GO, of vulvar carcinoma [30] and
H5N1 influenza infected lungs [31] mostly identified enrichment
of only general biological process terms, such as ‘cell death’, ‘cell
growth’, ‘cell communication’ and ‘cell-to-cell signaling’. Although, the
lung analysis also identified enrichment of more specific GO
terms, such as ‘viral reproduction’, ‘chemotaxis’ and ‘vesicle-mediated
transport’. As the Cardiovascular Initiative has identified over a fifth
Table 2. Comparison of Ontologizer PAH-SSc microarray data analysis using GO annotation dataset with and without the human
protein annotations submitted by the Cardiovascular Initiative.
GO dataset including Cardiovascular Initiative
annotations
GO dataset without Cardiovascular Initiative
annotations
GO ID GO term p-value
p-value
(Adj)
Study
count
(t = 264)
Population
count
(t =18249) p-value
p-value
(Adj)
Study
count
(t = 264)
Population
count
(t =18244)
GO:0002376 immune system process 1.38E-20 0 77 1487 2.73E-18 0 71 1406
GO:0065007 biological regulation 1.15E-10 0 183 8119 3.02E-10 0 179 7943
GO:0050896 Response to stimulus 2.93E-10 0 155 6423 1.57E-09 0 151 6318
GO:0040011 Locomotion 8.55E-09 0 42 970 4.88E-07 0 36 883
GO:0016265 Death 1.56E-08 0 53 1431 6.33E-09 0 52 1354
GO:0023052 Signaling 1.76E-08 0 107 4017 6.16E-09 0 106 3898
GO:0006928 cellular component movement 6.01E-08 0 35 701 9.27E-07 0 30 612
GO:0032502 developmental process 1.15E-07 0 98 3678 1.67E-07 0 95 3553
GO:0001775 cell activation 1.73E-07 0.002 32 632 7.56E-06 0 27 575
GO:0006950 Response to stress 4.68E-07 0.002 92 2552 1.57E-05 0.004 84 2448
GO:0008283 cell proliferation 3.15E-06 0.002 42 1205 2.37E-05 0.006 37 1091
GO:0009987 cellular process 1.27E-05 0.004 229 12453 7.36E-06 0 228 12356
GO:0032501 multicellular organismal process 3.01E-05 0.008 117 5194 3.81E-05 0.01 114 5054
GO:0048518 positive regulation of biological
process
3.91E-05 0.01 87 2786 1.60E-04 0.05 78 2541
GO:0022610 biological adhesion 4.59E-05 0.01 30 827 5.74E-04 0.186 26 782
GO:0009605 Response to external stimulus 6.49E-05 0.014 44 1033 1.66E-04 0.05 40 952
GO:0001816 Cytokine production 6.75E-05 0.014 18 289 1.64E-03 0.458 13 227
GO:0048519 Negative regulation of biological
process
7.13E-05 0.016 77 2404 4.42E-04 0.144 68 2190
GO:0051674 localization of cell 7.73E-05 0.016 29 606 1.27E-03 0.37 23 515
GO:0051179 Localization 1.14E-04 0.038 87 3669 2.48E-04 0.078 82 3482
GO:0065008 regulation of biological quality 1.80E-04 0.06 72 2199 2.39E-04 0.076 67 2024
GO:0042221 Response to chemical stimulus 2.13E-04 0.076 74 2177 1.25E-03 0.364 67 2048
GO:0046209 nitric oxide metabolic process 2.41E-04 0.094 6 51 2.88E-02 1 3 40
GO:0003013 circulatory system process 9.57E-04 0.318 12 263 2.16E-04 0.068 12 226
Significant adjusted p-values are highlighted in bold text. GO processes with adjusted p-values,0.1 identified by Ontologizer [24] are considered as significantly
enriched. t = number of protein IDs.
doi:10.1371/journal.pone.0027541.t002
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of the human proteome (4,000 proteins) as relevant to cardiovas-
cular processes, and with the number of renal protein targets
increasing (and currently standing at over 1,300), neither of these
annotation projects should be considered as narrowly focused
efforts. However, this concern does highlight the importance of
annotation providers being able to instigate complementary
annotation efforts to enhance annotations and terms across a
diverse set of proteins. For example, future projects could prioritize
the focused annotation of all the subunits in a specific subcellular
component, or protein families with similar catalytic activities
across closely-related organisms.
Lack of annotation data can lead to investigators to focus only
on genes they recognise [32,33] or to manually annotate genes in
their own study groups [22,33,34]. These types of approaches can
potentially bias data integration and result in valuable targets
being over-looked. However, as targeted manual annotation
appears to be becoming standard practice, we have demonstrated,
through the comprehensive annotation of a few proteins within a
microarray dataset, that focused annotation can have a significant
impact on data interpretation (Table 4).
Understanding the variability in the annotation of the human
proteome should enable users to interpret their analyses in a more
critical manner. As with all term enrichment analyses, care must
always be taken when interpreting some of the identified GO
terms, and users need to consider whether enrichment of the more
general parent terms is more physiologically relevant, or whether
the term provides a meaningful interpretation of the data at all.
For example, ‘biological regulation’, ‘negative regulation of biological
process’ and ‘cellular process’ are high-level, (i.e. non-specific) GO
terms that convey little information about the exact role of a gene
product in a specific process. These types of terms appear quite
regularly in GO term enrichment analyses as a large percentage of
Table 3. Comparison of ProfCom GO PAH-SSc microarray data analysis using GO annotation dataset with and without the human
protein annotations submitted by the Cardiovascular Initiative.
GO dataset including Cardiovascular Initiative
annotations
GO dataset without Cardiovascular Initiative
annotations
GO ID GO term p-value
Study count
(t = 265)
Population count
(t = 18257) p-value
Study count
(t = 265)
Population count
(t =18252)
GO:0032496 response to lipopolysaccharide 5.45E-05 12 107 1.22E-03 10 95
GO:0006954 inflammatory response 2.03E-04 16 224 1.59E-02 13 214
GO:0045768 positive regulation of anti-apoptosis 5.28E-04 7 34 2.06E-03 6 27
GO:0045429 postive regulation of nitric oxide
biosynthetic process
1.75E-03 6 26 #N/A #N/A #N/A
GO:0006955 immune response 1.82E-03 23 510 1.30E-03 23 502
GO:0048661 positive regulation of smooth muscle
cell proliferation
2.22E-03 6 27 6.23E-03 5 19
GO:0014070 response to organic cyclic substance 3.02E-03 10 104 2.82E-03 10 104
GO:0050900 leukocyte migration 3.60E-03 10 106 1.94E-02 9 103
GO:0051412 response to corticosterone stimulus 6.69E-03 5 19 6.23E-03 5 19
GO:0019221 cytokine-mediated signaling pathway 9.66E-03 13 203 1.32E-01 11 194
Significant p-values are highlighted in bold text. GO processes with p-values,0.01 identified by ProfCom GO [25] are considered as significantly enriched. t = number
of protein IDs.
doi:10.1371/journal.pone.0027541.t003
Table 4. Comparison of Ontologizer macrophage data analysis using GO annotation datasets from December 2010 and April 2011.
April 2011 December 2010
GO ID GO term p-value (Adj)
Study count
(t =257)
Population count
(t = 14241) p-value (Adj)
Study count
(t = 258)
Population count
(t =14386)
GO:0001775 cell activation 0 25 390 0.01 19 363
GO:0002376 immune system process 0 39 885 0.016 31 833
GO:0008283 cell proliferation 0 38 862 0.236 27 800
GO:0001816 cytokine production 0.002 16 220 1 8 205
GO:0042221 response to chemical stimulus 0.028 55 1538 1 37 1356
GO:0006928 cellular component movement 0.038 24 531 1 12 483
GO:0051674 localization of cell 0.066 23 507 1 11 457
GO:0032502 developmental process 0.068 81 3006 0.982 65 2832
GO:0071887 leukocyte apoptosis 0.092 7 41 1 2 24
Significant p-values are highlighted in bold text. GO processes with adjusted p-values,0.1 identified by Ontologizer [24] are considered as significantly enriched. t =
number of protein IDs.
doi:10.1371/journal.pone.0027541.t004
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gene products will be involved in one or several cellular processes,
or regulation thereof, but it does not add any value to the
interpretation of a dataset to regard these non-specific terms as
important. The continuing development of existing (and new) tools
and the lack of information in published papers about the source
of the annotation datasets, the ontology and tool versions and the
statistical methods used in an analysis make it impossible to
precisely reproduce the analysis of a dataset. Full disclosure of the
datasets and methods needs to become standard practice to enable
the interpretation of high-throughput datasets to be reproducible
and accountable. Our multiple analyses have confirmed that
despite considerable variation in the number of GO terms
enriched, many of the key processes, which would be expected
to be associated with PAH-SSc disease phenotype, are significantly
over-represented in each of the output files from a variety of
different tools. This demonstrates a current need to use
appropriate, as well as a variety, of term enrichment tools for
the evaluation of a high-throughput dataset, to ensure a balanced
and reproducible interpretation (for information about the choice
of term enrichment tools see Rhee et al. [35]).
The impact of both the Renal and Cardiovascular Initiatives on
renal and cardiovascular research can be greatly improved
through the involvement of experts from the respective research
communities and model organism databases. Consequently, a
range of online facilities have been made available to encourage
scientists to review and comment on GO annotations, suggest
improvements to the descriptiveness of renal and cardiovascular-
related GO terms and to suggest publications or proteins for
curation (available at www.ebi.ac.uk/GOA/contactus.html and
www.ucl.ac.uk/cardiovasculargeneontology/feedback). In this
way it is possible to ensure that current accumulated knowledge
has been comprehensively reviewed and correctly summarized by
the dedicated curation team. Members of these communities have
already participated in these initiatives and have contributed to the
consistent representation of a variety of processes across a range of
species.
Any biological community group who would be interested in
supporting the improved annotation of their area of expertise
should contact the authors, or members of the GO Consortium, to
discuss the options available.
Materials and Methods
Determination of number of annotations per protein
The QuickGO tool at http://www.ebi.ac.uk/QuickGO [5],
which supplies a comprehensive set of GO annotations for
UniProtKB proteins, was used to report the number of manual
annotations per proteins on 11th June 2011. This was achieved by
filtering for all manual human protein annotations in the UniProt
GOA dataset (i.e. restricted to taxon ID 9606 and all manual
evidence codes). The number of manual annotations per human
protein in the focused Cardiovascular and Renal Initiatives
prioritised protein lists was identified by including the ID filter
and selecting the BHF-UCL and KRUK protein lists.
Determination of GO term granularity
Granularity of annotations were measured by calculating the
maximum distance of a GO term from the root node terms either
‘GO:0008150 biological_process’, ‘GO:0003674 molecular_function’ and
‘GO:0005575 cellular_component’ using the transitive ‘is a’ and ‘part of’
GO relationships. Root node terms were given a granularity score
of one and direct descendant terms a score of two. Therefore, as
an example, a term supplied with granularity score of eight will
have seven terms between it and the root term as measured using
the connecting path in the ontology. The measurement of
granularity was based on the Gene Ontology CVS revision
4.1033 (July 8th 2011) at http://cvsweb.geneontology.org/cgi-bin/
cvsweb.cgi/go/ontology/gene_ontology.obo and the annotation
file gene_association.goa_human.99.gz (June 25th 2011).
Statistical analysis
The differing granularity distributions of GO term annotations
created by the Cardiovascular and Renal Initiatives and by the
other human protein annotation efforts which are not system
focused were compared using the Mann Whitney U test.
Microarray datasets used for analysis
The PAH-SSc dataset analysed used the 271 gene IDs identified
by microarray analysis of peripheral blood mononuclear cells from
5 normal versus 10 PAH-SSc patients using Affymetrix GeneChip
HG_U133A_2.0 The PAH-SSc-associated genes were identified
by filtering for a 2.45 fold-change and 1% false discovery rate [22].
The macrophage microarray dataset analysed used the 342
gene IDs identified as differentially expressed in peritoneal
resolving macrophages (n = 6) versus peritoneal naı¨ve (n = 6) and
pro-inflammatory (n = 6) macrophages using Affymetrix Gene-
Chip Mouse Genome 430 2.0 Array. Data is located in
GeneXpress, accession number E-MEXP-3189. The resolving
macrophage differentially expressed genes were identified by
filtering for 1.5 fold-change and 5% false discovery rate [26].
GO analysis tools
The background ‘population’ set used for all analyses of the
PAH-SSC dataset was the reviewed set of human proteins with the
‘Complete proteome’ keyword in UniProtKB (obtained on 1st
April 2011) with the exception of ProfCom GO which used all the
proteins present in the annotation file being analysed. The mouse
‘population’ set used was the reviewed set of mouse proteins with
the ‘Complete proteome’ keyword in UniProtKB (obtained on 6th
April 2011).
Reanalysis of the overexpression of GO terms was per-
formed using Ontologizer (http://compbio.charite.de/index.php/
ontologizer2.html [24]), ProfCom GO (http://www.bioprofiling.
de [25,36]), and GenMAPP GO-Elite (http://www.genmapp.org/
go_elite/ [23]).
GO term enrichment in Ontologizer was calculated using the
parent-child intersection analysis method [37] and uses a modified
Fisher’s exact analysis. The single-step minP procedure of
Westfall-Young was applied as multiple testing correction. Terms
were considered significantly enriched if the adjusted p-value was
,0.1.
BioProfiling.de (http://bioprofiling.de/) [25] provides an an-
alytical toolkit for the interpretation of a gene/protein list. The
gene list is profiled with respect to the most information available
regarding gene function, protein interactions, pathway relation-
ships, in silico predicted microRNA to gene associations, as well as
information collected by text mining. This study has made use of
the gene function (GO) profiling tool ProfCom [36]. Term
enrichment in ProfCom GO was performed on annotation files
described in the ‘Data files’ section below. ProfCom GO uses the
Monte-Carlo simulation approach for multiple testing correction
and hypergeometric/greedy heuristics. Terms were considered
significantly enriched if the p-value was ,0.01.
For GO-Elite analysis (http://www.genmapp.org/go_elite/
[23]) we used the EnsMart62plus database version with a z-score
cut-off of .1.96, the minimum number of changed genes was set
at 3 and the permuted p-value cut-off was ,0.05. GO-Elite uses
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the Z-score/hypergeometric statistical method and Benjamini-
Hochberg correction for multiple testing correction.
Data files
Ontology files were downloaded from: http://cvsweb.geneontology.
org/cgi-bin/cvsweb.cgi/go/ontology/gene_ontology.obo Gene Asso-
ciation Files (GO annotation datasets) were downloaded from: ftp://
ftp.ebi.ac.uk/pub/databases/GO/goa/old/HUMAN/ or ftp://ftp.
ebi.ac.uk/pub/databases/GO/goa/old/MOUSE/.
Files used for the analysis reported in Tables 1, 2, 3 and
S1. Gene Ontology revision 4.961 (March 8th 2011) and
annotation file: gene_association.goa_human.95.gz (March 7th
2011). For the filtered dataset the Cardiovascular Initiative (BHF-
UCL) annotations were removed from this file.
Files used for the analysis reported in Table 4. Gene
Ontology: revision 4.985 (April 13th 2011) and annotation files:
gene_association.goa_mouse.82.gz (April 6th 2011) and annotation
set; gene_association.goa_mouse.78.gz (December 13th 2010).
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